123 related articles for article (PubMed ID: 3621221)
21. Phase II study of etoposide in the treatment of esophageal carcinoma.
Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
[No Abstract] [Full Text] [Related]
22. Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study.
Nezhat F; Wadler S; Muggia F; Mandeli J; Goldberg G; Rahaman J; Runowicz C; Murgo AJ; Gardner GJ
Gynecol Oncol; 2004 Apr; 93(1):144-8. PubMed ID: 15047228
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barrett RJ; Gallup DG
Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
[TBL] [Abstract][Full Text] [Related]
24. Phase II trial of etoposide in the management of advanced and recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study.
Slayton RE; Blessing JA; Angel C; Berman M
Cancer Treat Rep; 1987 Dec; 71(12):1303-4. PubMed ID: 3690545
[No Abstract] [Full Text] [Related]
25. [Concurrent radiochemotherapy of primary squamous cell carcinoma of the vulva].
Bahnsen J
Strahlenther Onkol; 1996 May; 172(5):278-9. PubMed ID: 8633263
[No Abstract] [Full Text] [Related]
26. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
Leroi R
Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
[No Abstract] [Full Text] [Related]
27. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Rose PG; Blessing JA; Lewandowski GS; Creasman WT; Webster KD
Gynecol Oncol; 1996 Oct; 63(1):101-4. PubMed ID: 8898177
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?
Moore DH
Gynecol Oncol; 2009 Jun; 113(3):379-83. PubMed ID: 19232700
[TBL] [Abstract][Full Text] [Related]
29. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Yazigi R; Yordan E
Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222
[No Abstract] [Full Text] [Related]
30. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
[No Abstract] [Full Text] [Related]
31. Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley HD; Lewis GC
Gynecol Oncol; 1986 Mar; 23(3):358-63. PubMed ID: 3754234
[TBL] [Abstract][Full Text] [Related]
32. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
33. Mitoxantrone and advanced squamous cell carcinoma of the cervix: a Southwest Oncology Group Study.
Hilgers RD; Von Hoff DD; Stephens RL; Boutselis JG
Cancer Treat Rep; 1986 Apr; 70(4):527-8. PubMed ID: 3698047
[No Abstract] [Full Text] [Related]
34. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Fowler WC; Hatch K
Cancer Treat Rep; 1986 Sep; 70(9):1097-100. PubMed ID: 3755650
[TBL] [Abstract][Full Text] [Related]
35. Vulvar carcinoma treated successfully.
Chamoun CD; Downing V; Huseby RA
Rocky Mt Med J; 1974 Feb; 71(2):89-93. PubMed ID: 4811717
[No Abstract] [Full Text] [Related]
36. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley HD; Berek JS; Creasman WT
Gynecol Oncol; 1986 Jan; 23(1):101-4. PubMed ID: 3943746
[TBL] [Abstract][Full Text] [Related]
37. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck.
Khafif A; Canfield VA; Syzek EJ; Medina JE
Am J Otolaryngol; 2003; 24(1):1-5. PubMed ID: 12579475
[TBL] [Abstract][Full Text] [Related]
38. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases.
Piura B; Masotina A; Murdoch J; Lopes A; Morgan P; Monaghan J
Gynecol Oncol; 1993 Feb; 48(2):189-95. PubMed ID: 8428690
[TBL] [Abstract][Full Text] [Related]
39. A clinical trial of bleomycin on carcinoma of the vulva: a preliminary report.
Srivannaboon S; Boonyanit S; Vatananusara C; Sophak P
J Med Assoc Thai; 1973 Feb; 56(2):101-8. PubMed ID: 4119702
[No Abstract] [Full Text] [Related]
40. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
